HHS builds senior staff
HHS Deputy Assistant Secretary for Public Health Emergency Preparedness William Raub will serve as Acting Counselor for Science Policy. Raub will be a senior policy advisor to Secretary Michael Leavitt, with responsibilities including FDA issues. He formerly sat on HHS' drug importation task force, which said the practice would be costly, risky and harmful to innovation (1"The Pink Sheet" Jan. 3, 2005, p. 28). Assistant Secretary for Legislation Jennifer Young will serve as Acting Senior Counselor for Health Policy, a new position. Young will advise Leavitt on health care issues including Medicare and Medicaid...
You may also be interested in...
The Bush Administration would accept a Canada-only importation program that focuses solely on high volume brands, HHS Secretary Thompson and Commerce Secretary Donald Evans indicated in a Dec. 21 letter to Congress
Hanmi partner Athenex has had a US complete response letter for its oral paclitaxel plus encequidar product for the treatment of metastatic breast cancer, amid concerns of safety risks associated with an increase in neutropenia-related sequelae. While the decision marks another setback for Hanmi in the US, Athenex is aiming to resolve the issues.
Chordia only came into being in late 2017 but has already struck its first major licensing-out deal with a major pharma firm. It is now looking ahead to taking forward a portfolio of novel oncology assets originally acquired from investor Takeda.